Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter Surgical Treatment of Central Retinal Vein Occlusion (ROVO Study)
2005-003177-24Phase 3Active
- Sponsor
- Dr. José GarcÃa-ArumÃ
- Start
- Nov 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of triamcinolone acetonide in central retinal vein occlusion (CRVO), sponsored by Dr. José GarcÃa-ArumÃ. Primary endpoint: Best-corrected visual acuity improvement after 1 year. Started Nov 2005; status: active.
02
Drugs
triamcinolone acetonide
03
Conditions
central retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on 2005-003177-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003177-24.